Aardvark Therapeutics CEO Tien Lee on this month's $85M series C and leveraging TAS2R to modulate hunger and as a weight loss strategy
- May 28, 2024
- 1 min read
Tien Lee describes how TAS2R is a bitter taste receptor that naturally activates gut hormones and gut-brain signaling, and can be used to dampen hunger.














.png)

